Implications for pharmaceutical companies and clinicians from the Bayer v NHS judgement: an increasing budgetary focus for both.

Name: Implications for pharmaceutical companies and clinicians from the Bayer v NHS judgement: an increasing budgetary focus for both.
Author: Hyry, Hanna I

Implications for pharmaceutical companies and clinicians from the Bayer v NHS judgement: an increasing budgetary focus for both. — المؤلف: Hyry, Hanna I — Eye (London, England) 20190812

المؤلف: Hyry, Hanna I
النشر: Eye (London, England) 20190812
الوصف: 521-528 p.
الموضوعات: Drug Industry؛ Humans؛ Off-Label Use؛ State Medicine